![Mark Scapens](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Scapens is a professional who currently holds two positions as a Non-Executive Director at Cannasouth Ltd. and as a Director at Eqalis Pharmaceuticals Ltd. He previously worked as a Non-Executive Director at Aspire2 Group Ltd.
| Unternehmen | Position | Beginn |
|---|---|---|
| CANNASOUTH LIMITED | Direktor/Vorstandsmitglied | - |
Eqalis Pharmaceuticals Ltd
 Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Manufactures cannabis based pharmaceuticals | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
Aspire2 Group Ltd.
 Aspire2 Group Ltd. Miscellaneous Commercial ServicesCommercial Services Provides education and vocational training | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Aspire2 Group Ltd.
Aspire2 Group Ltd. Miscellaneous Commercial ServicesCommercial Services Provides education and vocational training | Commercial Services |
Cannasouth Ltd.
 Cannasouth Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company that researches and develops medicinal cannabis-based products | Health Technology |
Eqalis Pharmaceuticals Ltd
Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Manufactures cannabis based pharmaceuticals | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
